ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2228

Feasibility, Safety, and Application for Clinical Indication and Research Purposes of Synovial Tissue Analysis in Rheumatoid Arthritis

VAN MULLEM Cécile1, VIAILLE Charlotte1, DIERCKX Stéphanie2, NATALUCCI Francesco3, Clément triaille4, SAPART Emilie1, de MONTJOYE Stéphanie1, SOKOLOVA Tatiana1, AVRAMOVSKA Aleksandra1, NZEUSSEU TOUKAP Adrien5, MERIC de BELLEFON Laurent1 and DUREZ Patrick1, 1Cliniques Universitaires Saint-Luc – Université catholique de Louvain (UCLouvain) – Institut de Recherche Expérimentale et Clinique (IREC), Rheumatology, Brussels, Belgium, 2Cliniques Universitaires Saint-Luc – Université catholique de Louvain (UCLouvain) – Institut de Recherche Expérimentale et Clinique (IREC), Rheumatology, Bruxelles, Belgium, 3Sapienza University of Roma, Rheumatology, Department of Clinical, Internistic, Anesthesiological and cardiovascular sciences, Roma, Italy, 4Pôle de pathologies rhumatismales systémiques et inflammatoires, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Brussels, Belgium, Brussels, Belgium, 5Institut de Recherche Expérimentale et Clinique, Cliniques universitaires Saint-Luc, Université catholique de Louvain, St.-Lambrechts-Woluwe, Belgium

Meeting: ACR Convergence 2024

Keywords: rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 18, 2024

Title: RA – Diagnosis, Manifestations, & Outcomes Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: The development of ultrasound-guided synovial biopsy (US-SB) in addition to the knee mini-arthroscopy enabled synovial tissue collection from small and medium joints and facilitated molecular studies. This technique will help to improve the understanding of mechanisms of inflammatory arthropathies as small joints are frequently involved in early arthritis. To assess the safety, tolerability, and feasibility of performing synovial biopsies using a minimally US-SB or a mini arthroscopy in patients suffering from rheumatoid arthritis (RA) in our UCLouvain Brussels arthritis cohort.

Methods: A post-hoc analysis of our arthritis cohort was performed in patients suffering from RA, Undifferentiated arthritis (UA), peripheral Spondyloarthropathies (SA), and osteoarthrosis (OA). The target joints [(knee, wrist, MCP, PIP, MTP] selected for biopsy were analyzed for safety, tolerability, and feasibility. For each patient swelling and tenderness, were determined four weeks after the procedure in the biopsied joint.   In addition, the quality of the synovial tissue and total RNA were assessed.

Results: 466 biopsies were reported among patients suffering from RA (N=276, 59.2%), SA (113, 24.2%), UA (N=52, 11.1%), and OA (N=25, 5.3%) performed primarily for research or a clinical indication. Focusing on RA patients the median age at biopsy was 50.7±14.6 years. Figure 1 summarizes the joint biopsy location. Knee biopsies were performed with mini-arthroscopy (N=169, 61.2%) and US-GB for all other joints [wrist (N=53,19%), MCP (N=28,10%), MTP (N=14, 5%), PIP (N=6, 2%) joints, elbow (N=3, 1%) and tenosynovial tissue (N=3, 1%)]. Regarding US-SB, the pre-procedure ultrasound evaluation from a blinded operator confirmed the feasibility of the procedure in 63% of the biopsy-eligible patients identified by clinicians. An intra-articular steroid was administered after 83 (31.3%) of the procedures. No significant increase in pain and swelling was reported. No side effects (including infection, hemorrhage, or tendon rupture) were observed. At the visit (4 weeks) after the procedure, 125 patients (45.3%) did not show tenderness or swelling in the biopsied joint, 26 (9.4%) tenderness, 27 (9.7%) swelling, and 71 (25.7%) both. The positive yield in the total cohort of synovial biopsies was 86% for histological evaluation; in particular, the yield was statistically superior in large joints compared to small joints (120/133, 90.2% versus 69/87,79.3%; p=0.03).   Moreover, collected tissue samples were qualitatively adequate for RNA analysis in 92% of cases. Extrapolated data from this cohort, demonstrated that histology can predict treatment response to cDMARDs in early RA (1) and RNA analysis reflects clinical disease activity (2)

Conclusion: Our results over 466 procedures, support the safety and tolerability of both mini-arthroscopy and ultrasound-guided synovial biopsies. We found a good yield for both techniques, while mini-arthroscopy was slightly superior for histological analysis. We confirm that synovial analysis is an useful approach in clinical practice and translational research.

Supporting image 1

Figure 1. Homunculus showing biopsy sites. The number in each joint represents % of the total (N=276)


Disclosures: V. Cécile: None; V. Charlotte: None; D. Stéphanie: None; N. Francesco: None; C. triaille: None; S. Emilie: None; d. Stéphanie: None; S. Tatiana: None; A. Aleksandra: None; N. Adrien: None; M. Laurent: None; D. Patrick: None.

To cite this abstract in AMA style:

Cécile V, Charlotte V, Stéphanie D, Francesco N, triaille C, Emilie S, Stéphanie d, Tatiana S, Aleksandra A, Adrien N, Laurent M, Patrick D. Feasibility, Safety, and Application for Clinical Indication and Research Purposes of Synovial Tissue Analysis in Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/feasibility-safety-and-application-for-clinical-indication-and-research-purposes-of-synovial-tissue-analysis-in-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/feasibility-safety-and-application-for-clinical-indication-and-research-purposes-of-synovial-tissue-analysis-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology